Browse the full directors' dealings record of 강스템바이오텍, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 강스템바이오텍 has logged 35 public disclosures. Market capitalisation: €218.2bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 세종. The full history is free.
35
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.